Modern Medicine

 

Drug information bulletin, 31 _06_

Drug Information Bulletin
Drug Information Centre (DIC)
Indian Pharmaceutical Association
Bengal Branch
Tele fax: 033 24612776, E-mailWeb Site
Volume: 06
Number: 30 4th November 2012
• Final Report of FIP Challenge on TB Round 1 published in August 2012 by
SEARPharm Forum

• Cipla cuts prices of 3 cancer drugs by up to 63%
• Supreme Court of Canada invalidates Pfizer’s Viagra Patent
• Five common causes of Medical Device failure
• The 15 best selling drugs of 2012
• Forthcoming Events

Final Report of FIP Challenge on TB Round 1 published in August 2012 by
SEARPharm Forum


Cipla cuts prices of 3 cancer drugs by up to 63%
Cipla, one of India’s largest generic-drug manufacturers, on Thursday said it is reducing prices of three of its anti-cancer drugs by up to 63 per cent. According to the company, the move is part of its commitment to make medicines affordable and accessible, The company has reduced the price of Erlotinib (Erlocip), Docetaxel (Docetax) and Capecitabine (Capegard). These drugs are for the treatment of lung and pancreatic cancer, breast cancer, head and neck cancer, gastric cancer, bladder, colorectal and colon In May, Cipla had announced a similar price cut in three major anti-cancer drugs — Sorafenib (Soranib), Gefitinib (Gefticip) and Temozolomide (Temoside). “Continuing its contribution towards affordable and accessible treatment for patients, Cipla extends the work done in HIV/AIDS and Malaria to now includes Cancer, not only in India but globally,” said Y K Hamied, chairman and managing director, Cipla. According to Cipla, the company has always been committed to the treatment and care of cancer patients. As part of this commitment, in 1997, it established the Cipla Palliative Care and Training Centre in Pune, to provide care to advanced stage cancer patients. The centre provides free treatment and has cared for over 8,000 patients til date. It has also trained a large number of nurses in advanced palliative care.
Supreme Court of Canada
invalidates Pfizer’s Viagra Patent
invalidated Pfizer's Viagra patent, opening the popular erectile dysfunction drug. In Pfizer's patent, saying it tried to "game" company can begin selling its own version of the drug. The ruling wipes out Pfizer's Five common causes of Medical
Device failure
Medical device failures can be disastrous, causes of medical device failures and tips The 15 best selling drugs of 2012
The drug: Insulin Glargine (rDNA origin) waste. The once-mighty Lipitor is finished as a big earner, as we see in our new list The companies: Abbott Laboratories/Eisai Forthcoming Events:
IPA Bengal Branch celebrating
Theme: Pharmacist in Public Health
Tentative programme:
25.11.2012: Inauguration at Sisir Muncha, 29.11.2012: Rally & Seminar at Institute of First International Conference of
International Society for
Pharmacoeconomics and Outcome
Estimate worldwide sales for 2012: $5.01 Research-India Chapter
23-24th November 2012
India Habitat Centre,
Jacaranda Hall
Lodhi Road, New Delhi - 110003,
For Details Contact:
Prof. S. K. Gupta
President, ISPOR-India Chapter
Web site:

Source: http://www.ipapharma.org/news/Drug%20Information%20Centre%20Bulletin%20Volume%206/Drug_Information_Bulletin__31__06.pdf

Adult medical intake - part 3

Adult Medical Questionnaire WELLSPRING FAMILY MEDICAL ASSOCIATES 48. Any other family history we should know about? ___________________________________________________________________ 49. What is the attitude of those close to you about your illness? ! FOR WOMEN ONLY (questions 50-58): !50.Have you ever been pregnant? (If no, skip to question 53.) ! Number of miscarriages _____ Number of a

Team leader name

Team leader name: P. Vicendo Laboratory/ Service: IMRCP Title of the team: Colloids and Nanomedicine Project (CNP) Research staff: Permanent staff: Fitremann J (CR CNRS); Gauffre F (CR CNRS) ; Gineste S (IE CNRS) ; Lauth de Viguerie N (Pr.) ; Lonetti B (CR CNRS); Marty J-D (MdC); Mingotaud C (DR CNRS); Mingotaud A-F (CR CNRS); Souchard J-P (Pr.); Vicendo P. (CR CNRS) Non perman

© 2010-2018 Modern Medicine